SCHEMBL1630403

SCHEMBL1630403

CC(C)C(C)N(C(C)C)C(C)C

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.31
TSHR P16473 1/20 0.31
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13417336 1.00 ALDH1A1 (0.31) ALDH1A1TSHRHSD17B10
SCHEMBL21375499 1.00 ALDH1A1 (0.31) ALDH1A1TSHRHSD17B10
SCHEMBL1022725 0.82 ALDH1A1 (0.36) ALDH1A1TSHRHSD17B10
SCHEMBL22407 0.71 ALDH1A1 (0.30) ALDH1A1TSHRHSD17B10
SCHEMBL3751552 0.71 ALDH1A1 (0.30) ALDH1A1TSHRHSD17B10
SCHEMBL29199003 0.69
SCHEMBL11750507 0.69
SCHEMBL28869040 0.69 ALDH1A1 (0.33) ALDH1A1TSHR
Water SCHEMBL2864553 0.67
Bromide SCHEMBL4443445 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 515 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119638631-A Preparation method of key intermediate of agoraphobia 安徽皓元药业有限公司 2025-03-18 CN claimed
WO-2023245857-A1 CAPSAICIN-DERIVED PHOTOSENSITIZER, AND PREPARATION METHOD THEREFOR AND USE THEREOF 苏州大学 2023-12-28 WO claimed
US-20210139539-A1 NEW ANTIBACTERIAL PRODUCTS THE UNIVERSITY OF LIVERPOOL (GB) 2021-05-13 US claimed
CN-110582506-A Novel antimicrobial products 林肯大学 2019-12-17 CN claimed
WO-2018162922-A1 NEW ANTIBACTERIAL PRODUCTS UNIVERSITY OF LINCOLN (GB) 2018-09-13 WO claimed
US-7345165-B2 Method for preparing water-soluble free amine chitosan JAE WOON NAH (KR) 2008-03-18 US claimed
CN-1289533-C Process for preparing water-soluble free amine chitosan JUNG TEUK RAE (KR) 2006-12-13 CN claimed
CN-1592757-A Method for preparaing water-soluble free amine chitosan JUNG TEUK RAE (KR) 2005-03-09 CN claimed
US-20040260077-A1 Method for preparaing water-soluble free amine chitosan JEONG, TUK RAI (KR) 2004-12-23 US claimed
WO-2003035700-A1 METHOD FOR PREPARING WATER-SOLUBLE FREE AMINE CHITOSAN NAH JAE WOON (KR) 2003-05-01 WO claimed
US-20260068886-A1 COMPOSITIONS AND METHODS FOR TARGETED INHIBITION AND DEGRADATION OF PROTEINS IN AN INSECT CELL OERTH BIO LLC (US) 2026-03-12 US disclosed
US-20260008757-A1 N-(3-(AMINOMETHYL)-PHENYL)-5-(4-PHENYL)-5-(TRIFLUOROMETHYL)-4,5-DIHYDROISOXAZOL-3-AMINE DERIVATIVES AND SIMILAR COMPOUNDS AS PESTICIDES BASF SE (DE) 2026-01-08 US disclosed
EP-4615855-A2 NEW ANTIBACTERIAL PRODUCTS University of Liverpool (GB) 2025-09-17 EP disclosed
EP-4580405-A1 COMPOSITIONS AND METHODS FOR TARGETED INHIBITION AND DEGRADATION OF PROTEINS IN AN INSECT CELL Oerth Bio LLC (US) 2025-07-09 EP disclosed
CN-120152959-A N- (3- (aminomethyl) -phenyl) -5- (4-phenyl) -5- (trifluoromethyl) -4, 5-dihydroisoxazol-3-amine derivatives and similar compounds as pesticides 巴斯夫欧洲公司 2025-06-13 CN disclosed
US-5284851-A Controlling insects, arachnids and nematodes BASF AKTIENGESELLSCHAFT (DE) 1994-02-08 US disclosed
WO-1993016985-A1 CYANO-OXIME ETHERS, PROCESS FOR PRODUCING THEM, AGENTS CONTAINING THEM AND THEIR USE BASF AKTIENGESELLSCHAFT (DE) 1993-09-02 WO disclosed
EP-0513580-A2 Alpha-phenyl-acrylic acid derivatives, process for their preparation and their use as parasiticides and fungicides BASF Aktiengesellschaft (DE) 1992-11-19 EP disclosed
EP-0508190-A1 1-Alkoxy-1,3-diazacyclo alkane derivatives, process for their preparation and their use as pesticides BASF Aktiengesellschaft (DE) 1992-10-14 EP disclosed
CN-1043716-A Be used for the treatment of the heterocycleamide prostaglandin analogue that thrombus and angiospastic 7-oxabicyclo heptyl replace SQUIBB & SONS INC (US) 1990-07-11 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210139539-A1 NEW ANTIBACTERIAL PRODUCTS DBI, MRPL21, NRDC ALDH1A1 1816/4885TSHR 4683/4885HSD17B10 1891/4885
US-20260008757-A1 N-(3-(AMINOMETHYL)-PHENYL)-5-(4-PHENYL)-5-(TRIFLUOROMETHYL)-4,5-DIHYDROISOXAZOL-3-AMINE DERIVATIVES AND SIMILAR COMPOUNDS AS PESTICIDES HCN1, HCN3, HTR3C ALDH1A1 1430/4885TSHR 1877/4885HSD17B10 2513/4885
US-20260068886-A1 COMPOSITIONS AND METHODS FOR TARGETED INHIBITION AND DEGRADATION OF PROTEINS IN AN INSECT CELL CRBN, STUB1, CUL1 ALDH1A1 3713/4885TSHR 2053/4885HSD17B10 3531/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.